id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-0390-0025,FDA,FDA-2015-D-0390,"Use of Electronic Informed Consent—Questions and Answers; Guidance for Institutional Review Boards, Investigators, and Sponsors; Availability",Notice,Notice of Availability,2016-12-15T05:00:00Z,2016,12,2016-12-15T05:00:00Z,,2016-12-15T15:09:26Z,2016-30146,0,0,090000648240b6b5
FDA-2015-D-0390-0026,FDA,FDA-2015-D-0390,"Use of Electronic Informed Consent Questions and Answers Guidance for Institutional Review Boards, Investigators, and Sponsors",Other,Guidance,2016-12-15T05:00:00Z,2016,12,2016-12-15T05:00:00Z,,2024-11-12T06:17:18Z,,1,0,090000648240bb40
FDA-2015-D-0390-0001,FDA,FDA-2015-D-0390,"Use of an Electronic Informed Consent in Clinical Investigations: Questions and Answers; Draft Guidance for Industry, Clinical Investigators, and Institutional Review Boards; Availability",Notice,Notice of Availability,2015-03-09T04:00:00Z,2015,3,2015-03-09T04:00:00Z,2015-05-09T03:59:59Z,2015-05-12T01:31:54Z,2015-05377,0,0,0900006481a342e8
FDA-2015-D-0390-0002,FDA,FDA-2015-D-0390,"Use of an Electronic Informed Consent in Clinical Investigations: Questions and Answers; Draft Guidance for Industry, Clinical Investigators, and Institutional Review Boards",Other,Guidance,2015-03-09T04:00:00Z,2015,3,2015-03-09T04:00:00Z,,2019-06-19T19:39:48Z,,0,0,0900006481a3456c